ICAM1 and COVID-19: The most severe forms of COVID-19 ARDS are characterized by the predominance of the “endothelial” over the “alveolar” injury, as detected by the higher levels of Ang-2 and ICAM-1 in non-survivors compared to survivors; COVID-19 ARDS and classical ARDS had similar loss in gas exchange, but exhibited a different expression of biomarkers, suggesting different pathological pathways.